339 related articles for article (PubMed ID: 12771005)
1. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction.
Kühl U; Pauschinger M; Schwimmbeck PL; Seeberg B; Lober C; Noutsias M; Poller W; Schultheiss HP
Circulation; 2003 Jun; 107(22):2793-8. PubMed ID: 12771005
[TBL] [Abstract][Full Text] [Related]
2. Viral persistence in the myocardium is associated with progressive cardiac dysfunction.
Kühl U; Pauschinger M; Seeberg B; Lassner D; Noutsias M; Poller W; Schultheiss HP
Circulation; 2005 Sep; 112(13):1965-70. PubMed ID: 16172268
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction.
Kühl U; Pauschinger M; Noutsias M; Seeberg B; Bock T; Lassner D; Poller W; Kandolf R; Schultheiss HP
Circulation; 2005 Feb; 111(7):887-93. PubMed ID: 15699250
[TBL] [Abstract][Full Text] [Related]
4. Predictors of outcome in patients with suspected myocarditis.
Kindermann I; Kindermann M; Kandolf R; Klingel K; Bültmann B; Müller T; Lindinger A; Böhm M
Circulation; 2008 Aug; 118(6):639-48. PubMed ID: 18645053
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction.
Tschöpe C; Bock CT; Kasner M; Noutsias M; Westermann D; Schwimmbeck PL; Pauschinger M; Poller WC; Kühl U; Kandolf R; Schultheiss HP
Circulation; 2005 Feb; 111(7):879-86. PubMed ID: 15710767
[TBL] [Abstract][Full Text] [Related]
6. Myocardial biopsy based classification and treatment in patients with dilated cardiomyopathy.
Zimmermann O; Kochs M; Zwaka TP; Kaya Z; Lepper PM; Bienek-Ziolkowski M; Hoher M; Hombach V; Torzewski J
Int J Cardiol; 2005 Sep; 104(1):92-100. PubMed ID: 16137516
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load.
Dennert R; Velthuis S; Schalla S; Eurlings L; van Suylen RJ; van Paassen P; Tervaert JW; Wolffs P; Goossens VJ; Bruggeman C; Waltenberger J; Crijns HJ; Heymans S
Antivir Ther; 2010; 15(2):193-201. PubMed ID: 20386074
[TBL] [Abstract][Full Text] [Related]
8. Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study.
Izawa H; Murohara T; Nagata K; Isobe S; Asano H; Amano T; Ichihara S; Kato T; Ohshima S; Murase Y; Iino S; Obata K; Noda A; Okumura K; Yokota M
Circulation; 2005 Nov; 112(19):2940-5. PubMed ID: 16275882
[TBL] [Abstract][Full Text] [Related]
9. Parvovirus B19 infection mimicking acute myocardial infarction.
Kühl U; Pauschinger M; Bock T; Klingel K; Schwimmbeck CP; Seeberg B; Krautwurm L; Poller W; Schultheiss HP; Kandolf R
Circulation; 2003 Aug; 108(8):945-50. PubMed ID: 12925460
[TBL] [Abstract][Full Text] [Related]
10. Detection of viral genome in the myocardium: lack of prognostic and functional relevance in patients with acute dilated cardiomyopathy.
Kuethe F; Sigusch HH; Hilbig K; Tresselt C; Glück B; Egerer R; Figulla HR
Am Heart J; 2007 May; 153(5):850-8. PubMed ID: 17452164
[TBL] [Abstract][Full Text] [Related]
11. Decreased myocardial free fatty acid uptake in patients with idiopathic dilated cardiomyopathy: evidence of relationship with insulin resistance and left ventricular dysfunction.
Tuunanen H; Engblom E; Naum A; Scheinin M; Någren K; Airaksinen J; Nuutila P; Iozzo P; Ukkonen H; Knuuti J
J Card Fail; 2006 Oct; 12(8):644-52. PubMed ID: 17045185
[TBL] [Abstract][Full Text] [Related]
12. [Detection of enteroviral RNA in endomyocardial biopsies in inflammatory cardiomyopathy and idiopathic dilated cardiomyopathy].
Pauschinger M; Kühl U; Dörner A; Schieferecke K; Petschauer S; Rauch U; Schwimmbeck PL; Kandolf R; Schultheiss HP
Z Kardiol; 1998 Jun; 87(6):443-52. PubMed ID: 9691414
[TBL] [Abstract][Full Text] [Related]
13. Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction.
Pauschinger M; Bowles NE; Fuentes-Garcia FJ; Pham V; Kühl U; Schwimmbeck PL; Schultheiss HP; Towbin JA
Circulation; 1999 Mar; 99(10):1348-54. PubMed ID: 10077520
[TBL] [Abstract][Full Text] [Related]
14. Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Seghatol FF; Shah DJ; Diluzio S; Bello D; Johnson MR; Cotts WG; O'Donohue JA; Bonow RO; Gheorghiade M; Rigolin VH
Am J Cardiol; 2004 Apr; 93(7):854-9. PubMed ID: 15050488
[TBL] [Abstract][Full Text] [Related]
15. Interferon beta-1b therapy in chronic viral dilated cardiomyopathy--is there a role for specific therapy?
Zimmermann O; Rodewald C; Radermacher M; Vetter M; Wiehe JM; Bienek-Ziolkowski M; Hombach V; Torzewski J
J Card Fail; 2010 Apr; 16(4):348-56. PubMed ID: 20350703
[TBL] [Abstract][Full Text] [Related]
16. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
Kobayashi M; Machida N; Mitsuishi M; Yamane Y
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
[TBL] [Abstract][Full Text] [Related]
17. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
Minczykowski A; Gryczynska M; Ziemnicka K; Czepczynski R; Sowinski J; Wysocki H
Growth Horm IGF Res; 2005 Apr; 15(2):156-64. PubMed ID: 15809020
[TBL] [Abstract][Full Text] [Related]
18. Current insights into the pathogenesis, diagnosis and therapy of inflammatory cardiomyopathy.
Noutsias M; Pauschinger M; Poller WC; Schultheiss HP; Kühl U
Heart Fail Monit; 2003; 3(4):127-35. PubMed ID: 12709733
[TBL] [Abstract][Full Text] [Related]
19. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
[TBL] [Abstract][Full Text] [Related]
20. Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices.
Vatankulu MA; Goktekin O; Kaya MG; Ayhan S; Kucukdurmaz Z; Sutton R; Henein M
Am J Cardiol; 2009 May; 103(9):1280-4. PubMed ID: 19406272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
